This interaction was found to be elevated in Alzheimer’s disease patients and correlated with greater pathological burden, thereby establishing a functional SIGLEC3-CD45 sialoglycan axis implicated in Alzheimer’s disease pathogenesis. The gene discussed is CD33; the disease is Alzheimer disease.